---
figid: PMC9237930__gr1
figtitle: 'New dawn for cancer cell death: Emerging role of lipid metabolism'
organisms:
- NA
pmcid: PMC9237930
filename: gr1.jpg
figlink: /pmc/articles/PMC9237930/figure/fig1/
number: F1
caption: The role of lipid metabolism reprogramming in cancer cell death. (A) Increased
  exogenous lipid uptake by CD36 and LDLR promote carcinogenesis. (B) A network regulates
  the four systems and the entire transportation process. The elevated expression
  of ABCA1, HDL/ApoA-1, SR-B1 and CAV-1 accelerate cholesterol efflux, which lead
  to cancer cell apoptosis. (C) The increment of cholesterol esterification regulated
  by ACAT1 induces apoptosis. (D) Glucose increases N-glycosylation of SCAP, activates
  SREBPs, ultimately inhibits apoptosis of cancer cells. The biosynthesis pathway
  converts acetyl-CoA into cholesterol through HMGCs and HMGCR, which are the key
  speed-limiting enzymes. (E) The upregulation of enzymes promotes fatty acid synthesis
  and oxidation, then induces ferroptosis. (F) PLA2 and LPCAT2 induce LDs formation,
  stimulates cancer cell survival, and prevents apoptosis.
papertitle: 'New dawn for cancer cell death: Emerging role of lipid metabolism.'
reftext: Chanjuan Zhang, et al. Mol Metab. 2022 Sep;63:101529.
year: '2022'
doi: 10.1016/j.molmet.2022.101529
journal_title: Molecular Metabolism
journal_nlm_ta: Mol Metab
publisher_name: Elsevier
keywords: Lipid metabolism | Cancer | Cell death | Therapeutic strategy
automl_pathway: 0.9269755
figid_alias: PMC9237930__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9237930__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9237930__gr1.html
  '@type': Dataset
  description: The role of lipid metabolism reprogramming in cancer cell death. (A)
    Increased exogenous lipid uptake by CD36 and LDLR promote carcinogenesis. (B)
    A network regulates the four systems and the entire transportation process. The
    elevated expression of ABCA1, HDL/ApoA-1, SR-B1 and CAV-1 accelerate cholesterol
    efflux, which lead to cancer cell apoptosis. (C) The increment of cholesterol
    esterification regulated by ACAT1 induces apoptosis. (D) Glucose increases N-glycosylation
    of SCAP, activates SREBPs, ultimately inhibits apoptosis of cancer cells. The
    biosynthesis pathway converts acetyl-CoA into cholesterol through HMGCs and HMGCR,
    which are the key speed-limiting enzymes. (E) The upregulation of enzymes promotes
    fatty acid synthesis and oxidation, then induces ferroptosis. (F) PLA2 and LPCAT2
    induce LDs formation, stimulates cancer cell survival, and prevents apoptosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MIR185
  - MIR342
  - CD36
  - CEBPA
  - CEBPB
  - CEBPD
  - CEBPG
  - CEBPE
  - VAMP3
  - SCAP
  - SH2D2A
  - KIF23
  - LDLR
  - ABCA1
  - MYLIP
  - MAPK3
  - MAPK1
  - ACACA
  - BCL2A1
  - ACAT1
  - SOAT1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - HMGCS1
  - ALOX12
  - HMGCR
  - NR1H2
  - NR1H3
  - HSD11B1
  - ALB
  - APOA1
  - APOA2
  - APOE
  - CLU
  - MIR183
  - AKT1
  - AKT2
  - AKT3
  - SCARB1
  - FASN
  - SCD
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - CAV1
  - ROCK1
  - LAMTOR5
  - SQSTM1
  - GTF2H1
  - KHDRBS1
  - NUP62
  - DCTN4
  - CPT1A
  - EGFR
  - EPHB2
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - ATG7
  - PLA2G1B
  - PLA2G2A
  - PLA2G6
  - PLA2G3
  - PLA2G5
  - PLA2G7
  - PLA2G10
  - PLA2G12A
  - PLA2G12B
  - PLA2G2C
  - PLA2G2D
  - PLA2G2E
  - PLA2G2F
  - PLA2G4A
  - PLA2G4C
  - PLA2G4D
  - LPCAT2
---
